United States · Bill · HR
H.R. 2739 (114th)
Cancer Drug Coverage Parity Act of 2015
Introduced
11 June 2015
Last action
12 June 2015 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Rep. Lance, Leonard [R-NJ-7], Rep. Higgins, Brian [D-NY-26], Rep. Fitzpatrick, Michael G. [R-PA-8], Rep. Smith, Christopher H. [R-NJ-4], Rep. Clark, Katherine M. [D-MA-5], Rep. Schakowsky, Janice D. [D-IL-9], Rep. Yarmuth, John A. [D-KY-3], Rep. Hastings, Alcee L. [D-FL-20], Rep. Israel, Steve [D-NY-3], Rep. Dent, Charles W. [R-PA-15], Rep. King, Peter T. [R-NY-2], Rep. Sensenbrenner, F. James, Jr. [R-WI-5], Rep. Hanna, Richard L. [R-NY-22], Rep. Maloney, Sean Patrick [D-NY-18], Rep. Langevin, James R. [D-RI-2], Rep. MacArthur, Thomas [R-NJ-3], Rep. Frelinghuysen, Rodney P. [R-NJ-11], Rep. Lofgren, Zoe [D-CA-18], Rep. Wittman, Robert J. [R-VA-1], Rep. Tonko, Paul [D-NY-20], Rep. Bishop, Mike [R-MI-8], Rep. Pingree, Chellie [D-ME-1], Rep. Young, Don [R-AK-At Large], Rep. Takai, Mark [D-HI-1], Rep. Burgess, Michael C. [R-TX-26], Sen. Van Hollen, Chris [D-MD], Rep. Jolly, David W. [R-FL-13], Rep. Engel, Eliot L. [D-NY-16], Rep. Ellmers, Renee L. [R-NC-2], Rep. Tiberi, Patrick J. [R-OH-12], David Scott, Rep. DeLauro, Rosa L. [D-CT-3], Sen. Mullin, Markwayne [R-OK], Rep. Grijalva, Raúl M. [D-AZ-7], David Trott, Rep. Rangel, Charles B. [D-NY-15], Rep. Miller, Candice S. [R-MI-10], Rep. LoBiondo, Frank A. [R-NJ-2], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Carter, Earl L. "Buddy" [R-GA-1], Rep. Kildee, Daniel T. [D-MI-5], Rep. Comstock, Barbara [R-VA-10], Rep. Maloney, Carolyn B. [D-NY-12], Rep. Fortenberry, Jeff [R-NE-1], Sen. Schiff, Adam B. [D-CA], Rep. Miller, Jeff [R-FL-1], Rep. DeFazio, Peter A. [D-OR-4], Rep. Ros-Lehtinen, Ileana [R-FL-27]
Subjects
Healthcare
Source updated
5 December 2025
Summary
Cancer Drug Coverage Parity Act of 2015 This bill amends the Public Health Service Act to require a group or individual health plan that covers anticancer medications administered by a health care provider to provide no less favorable coverage for anticancer medications administered by a patient. A plan may apply to patient-administered anticancer medications only the cost-sharing and limitations that apply to anticancer medications administered by a health care provider. These requirements apply to medication approved by the Food and Drug Administration that is prescribed based on a finding by the treating physician that the medication is medically necessary for cancer treatment and is clinically appropriate in terms of type, frequency, extent site, and duration. To comply with these requirements, health plans may not, for anticancer medications: (1) change or replace benefits to increase out-of-pocket costs; (2) reclassify benefits to increase costs; or (3) apply more restrictive limitations to orally administered medications than to intravenously administered or injected medications.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
11 June 2015
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
11 June 2015
Introduced
Introduced in House
Source: IntroReferral
11 June 2015
Introduced
Introduced in House
Source: IntroReferral
12 June 2015
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 11 June 2015 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 11 June 2015
Introduced in House (PDF)
Introduced in House · EN · 11 June 2015
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 11 June 2015
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Lance, Leonard [R-NJ-7] · R · Sponsor
- Rep. Higgins, Brian [D-NY-26] · D · Sponsor
- Rep. Fitzpatrick, Michael G. [R-PA-8] · R · Sponsor
- Rep. Smith, Christopher H. [R-NJ-4] · R · Sponsor
- Rep. Clark, Katherine M. [D-MA-5] · D · Sponsor
- Rep. Schakowsky, Janice D. [D-IL-9] · D · Sponsor
- Rep. Yarmuth, John A. [D-KY-3] · D · Sponsor
- Rep. Hastings, Alcee L. [D-FL-20] · D · Sponsor
- Rep. Israel, Steve [D-NY-3] · D · Sponsor
- Rep. Dent, Charles W. [R-PA-15] · R · Sponsor
- Rep. King, Peter T. [R-NY-2] · R · Sponsor
- Rep. Sensenbrenner, F. James, Jr. [R-WI-5] · R · Sponsor
- Rep. Hanna, Richard L. [R-NY-22] · R · Cosponsor
- Rep. Maloney, Sean Patrick [D-NY-18] · D · Cosponsor
- Rep. Langevin, James R. [D-RI-2] · D · Cosponsor
- Rep. MacArthur, Thomas [R-NJ-3] · R · Cosponsor
- Rep. Frelinghuysen, Rodney P. [R-NJ-11] · R · Cosponsor
- Rep. Lofgren, Zoe [D-CA-18] · D · Cosponsor
- Rep. Wittman, Robert J. [R-VA-1] · R · Cosponsor
- Rep. Tonko, Paul [D-NY-20] · D · Cosponsor
- Rep. Bishop, Mike [R-MI-8] · R · Cosponsor
- Rep. Pingree, Chellie [D-ME-1] · D · Cosponsor
- Rep. Young, Don [R-AK-At Large] · R · Cosponsor
- Rep. Takai, Mark [D-HI-1] · D · Cosponsor
- Rep. Burgess, Michael C. [R-TX-26] · R · Cosponsor
- Sen. Van Hollen, Chris [D-MD] · D · Cosponsor
- Rep. Jolly, David W. [R-FL-13] · R · Cosponsor
- Rep. Engel, Eliot L. [D-NY-16] · D · Cosponsor
- Rep. Ellmers, Renee L. [R-NC-2] · R · Cosponsor
- Rep. Tiberi, Patrick J. [R-OH-12] · R · Cosponsor
- David Scott · D · Cosponsor
- Rep. DeLauro, Rosa L. [D-CT-3] · D · Cosponsor
- Sen. Mullin, Markwayne [R-OK] · R · Cosponsor
- Rep. Grijalva, Raúl M. [D-AZ-7] · D · Cosponsor
- David Trott · R · Cosponsor
- Rep. Rangel, Charles B. [D-NY-15] · D · Cosponsor
- Rep. Miller, Candice S. [R-MI-10] · R · Cosponsor
- Rep. LoBiondo, Frank A. [R-NJ-2] · R · Cosponsor
- Del. Norton, Eleanor Holmes [D-DC-At Large] · D · Cosponsor
- Rep. Carter, Earl L. "Buddy" [R-GA-1] · R · Cosponsor
- Rep. Kildee, Daniel T. [D-MI-5] · D · Cosponsor
- Rep. Comstock, Barbara [R-VA-10] · R · Cosponsor
- Rep. Maloney, Carolyn B. [D-NY-12] · D · Cosponsor
- Rep. Fortenberry, Jeff [R-NE-1] · R · Cosponsor
- Sen. Schiff, Adam B. [D-CA] · D · Cosponsor
- Rep. Miller, Jeff [R-FL-1] · R · Cosponsor
- Rep. DeFazio, Peter A. [D-OR-4] · D · Cosponsor
- Rep. Ros-Lehtinen, Ileana [R-FL-27] · R · Cosponsor
Showing 48 of 125 sponsors and actors.
Related records
- related to → Cancer Drug Coverage Parity Act of 2015
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/114th-congress/house-bill/2739
- Open data entity: https://api.congress.gov/v3/bill/114/hr/2739
- us · 114-hr-2739 · source updated 5 December 2025